- Home
- PTEN vs IRON Comparison
PTEN vs IRON Comparison
Compare PTEN & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTEN
- IRON
- Stock Information
- Founded
- PTEN 1978
- IRON 2017
- Country
- PTEN United States
- IRON United States
- Employees
- PTEN N/A
- IRON N/A
- Industry
- PTEN Oil & Gas Production
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- PTEN Energy
- IRON Health Care
- Exchange
- PTEN Nasdaq
- IRON Nasdaq
- Market Cap
- PTEN 2.1B
- IRON 2.1B
- IPO Year
- PTEN 1993
- IRON N/A
- Fundamental
- Price
- PTEN $6.65
- IRON $85.63
- Analyst Decision
- PTEN Buy
- IRON Strong Buy
- Analyst Count
- PTEN 11
- IRON 13
- Target Price
- PTEN $7.68
- IRON $102.23
- AVG Volume (30 Days)
- PTEN 9.5M
- IRON 623.6K
- Earning Date
- PTEN 10-22-2025
- IRON 11-11-2025
- Dividend Yield
- PTEN 4.83%
- IRON N/A
- EPS Growth
- PTEN N/A
- IRON N/A
- EPS
- PTEN N/A
- IRON N/A
- Revenue
- PTEN $4,837,946,000.00
- IRON N/A
- Revenue This Year
- PTEN N/A
- IRON N/A
- Revenue Next Year
- PTEN N/A
- IRON N/A
- P/E Ratio
- PTEN N/A
- IRON N/A
- Revenue Growth
- PTEN N/A
- IRON N/A
- 52 Week Low
- PTEN $5.10
- IRON $30.82
- 52 Week High
- PTEN $9.58
- IRON $95.95
- Technical
- Relative Strength Index (RSI)
- PTEN 68.81
- IRON 69.02
- Support Level
- PTEN $5.45
- IRON $83.52
- Resistance Level
- PTEN $6.22
- IRON $89.00
- Average True Range (ATR)
- PTEN 0.29
- IRON 3.84
- MACD
- PTEN 0.12
- IRON 1.08
- Stochastic Oscillator
- PTEN 81.90
- IRON 64.05
About PTEN Patterson-UTI Energy Inc.
Patterson-UTI Energy Inc is one of the substantial land rig drilling contractors in the United States. Its 2023 merger with NexTier greatly expanded its pressure pumping operations, as well, and the firm now controls nearly 20% of the North American market for drilling and completions services. The company operates under three reportable business segments: (i) drilling services, (ii) completion services, and (iii) drilling products. It also provides directional drilling services and tool rental services in united states onshore oil and gas basins.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.